Vor Biopharma (VOR) Interest Coverage Ratio (2020 - 2026)
Vor Biopharma's (VOR) quarterly Interest Coverage Ratio came in at 319.64 in Q1 2026, down 1520.7% year-on-year from 22.5 in Q1 2025, and up 2.22% on a QoQ basis from 326.91 in Q4 2025.
Vor Biopharma (VOR) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Vor Biopharma (VOR) has 7 years of Interest Coverage Ratio data on file, last reported at 319.64 in Q1 2026.
- On a quarterly basis, Interest Coverage Ratio fell 1520.7% year-over-year to 319.64 in Q1 2026; TTM through Mar 2026 was 35.74, a 94.84% decrease from a year earlier, with the FY2025 full-year figure at 1.6, down 83.43% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 319.64, up from 326.91 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for VOR reached as high as 9.1 in Q4 2022 and fell as low as 780.75 in Q3 2025.
- Historically, Interest Coverage Ratio has averaged 132.41 across 5 years, with a median of 20.46 in 2022.
- Across the five-year window, Interest Coverage Ratio plunged 47078.32% in 2022 and surged 93.51% in 2025, its largest moves.
- Year by year, Interest Coverage Ratio stood at 9.1 in 2022, then retreated by 29.04% to 11.74 in 2023, then slumped by 58.24% to 18.58 in 2024, then sank by 1659.26% to 326.91 in 2025, then advanced by 2.22% to 319.64 in 2026.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 319.64 in Q1 2026, 326.91 in Q4 2025, and 780.75 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Vor Biopharma | 187.37 Mn | 187.37 Mn | - | -319.64 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -319.64 |
| Dec 31, 2025 | -326.91 |
| Sep 30, 2025 | -780.75 |
| Jun 30, 2025 | -26.90 |
| Mar 31, 2025 | -19.72 |
| Dec 31, 2024 | -18.58 |
| Sep 30, 2024 | -17.30 |
| Jun 30, 2024 | -414.79 |
| Mar 31, 2024 | -19.72 |
| Dec 31, 2023 | -11.74 |
| Sep 30, 2023 | -125.68 |
| Jun 30, 2023 | -72.14 |
| Mar 31, 2023 | -19.70 |
| Dec 31, 2022 | -9.10 |
| Sep 30, 2022 | -20.46 |
| Jun 30, 2022 | -16.43 |
| Mar 31, 2022 | -31.36 |
| Dec 31, 2021 | -25.46 |
| Sep 30, 2021 | -26.61 |
| Jun 30, 2021 | -26.29 |